Adaptive Biotechnologies ADPT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Adaptive Biotechnologies (ADPT) Business Model and Operations Summary
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Key Insights
Adaptive Biotechnologies (ADPT) Core Market Data and Business Metrics
Latest Closing Price
$7.94Market Cap
$1.18 BillionPrice-Earnings Ratio
-5.93Total Outstanding Shares
148.58 Million SharesTotal Employees
619Dividend
No dividendIPO Date
June 27, 2019SIC Description
Biological Products, (no Disgnostic Substances)Primary Exchange
NASDAQHeadquarters
1165 Eastlake Ave E, Seattle, WA, 98109
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,266,629 Shares | 4.19 | 3/14/2025 | 9,488,437 Shares |
| 1,560,337 Shares | 5.55 | 2/28/2025 | 8,663,017 Shares |
| 1,622,042 Shares | 5.41 | 2/14/2025 | 8,775,706 Shares |
| 1,358,325 Shares | 6.28 | 1/31/2025 | 8,530,375 Shares |
| 1,679,207 Shares | 5.16 | 1/15/2025 | 8,656,445 Shares |
| 1,009,701 Shares | 9.1 | 12/31/2024 | 9,189,671 Shares |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $201,000 |
| Net Cash Flow From Investing Activities | $58.88 Million |
| Net Cash Flow, Continuing | $-50.57 Million |
| Net Cash Flow | $-50.57 Million |
| Net Cash Flow From Operating Activities, Continuing | $-109.65 Million |
| Net Cash Flow From Financing Activities | $201,000 |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Benefits Costs and Expenses | $372.63 Million |
| Income/Loss From Continuing Operations After Tax | $-195.34 Million |
| Basic Average Shares | $440.89 Million |
| Operating Expenses | $303.41 Million |
| Operating Income/Loss | $-199.78 Million |
| Revenues | $177.28 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-194.60 Million |
| Comprehensive Income/Loss Attributable To Parent | $-194.49 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $747,000 |
| Other Comprehensive Income/Loss | $747,000 |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-104,000 |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $-199,000 |
| Other Non-current Assets | $198.85 Million |
| Fixed Assets | $51.31 Million |
| Current Assets | $308.35 Million |
| Inventory | $11.96 Million |
| Liabilities | $334.93 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||